Synaffix BV Investors

15 investors on Angel Roster list Synaffix BV in their portfolio. Most are venture capital firms and private equity firms, the most common stage is Seed and the largest groups are based in the Netherlands, Germany and Switzerland.

Investors are matched on the company name in their portfolio, so companies that share the name Synaffix BV can appear together.

Investors listed
15
With verified email
40%
Most common stage
Seed
Top location
Netherlands

Updated October 13, 2026 · How we compile this data

Top 15 Synaffix BV investors

The most complete profiles first. Showing 15 of 15.

  • Alexander VosVerified

    Venture Capital, Micro VC, Investor · Netherlands

    SeedPre-SeedHealth CareLife ScienceManufacturingBiotechnology

    Portfolio: Confo Therapeutics, Lanthio Pharma, Scenic Biotech, Cristal Therapeutics and 13 more

    Verified email available

  • Noga YerushalmiVerified

    Venture Capital, Corporate Venture Capital, Private Equity Firm · Israel

    SeedHealth CareConsumer GoodsInfrastructureLife Science

    Portfolio: FoRx Therapeutics, Micropsi Industries, Indi Molecular, Biolinq and 48 more

    Verified email available

  • Owen LozmanVerified

    Venture Capital, Corporate Venture Capital, Private Equity Firm · Netherlands

    SeedHealth CareConsumer GoodsInfrastructureLife Science

    Portfolio: FoRx Therapeutics, Micropsi Industries, Indi Molecular, Biolinq and 48 more

    Verified email available

  • Claudia ZimmermannVerified

    Venture Capital, Private Equity Firm · Switzerland

    Health CareWellnessWomen FoundedLife Science

    Portfolio: Borean Pharma, Ikaria, Synosia Therapeutics, MerLion Pharma and 15 more

    Verified email available

  • Javier RodriguezVerified

    Venture Capital, Corporate Venture Capital, Private Equity Firm · Germany

    Health CareConsumer GoodsInfrastructureLife Science

    Portfolio: FoRx Therapeutics, Micropsi Industries, Indi Molecular, Biolinq and 48 more

    Verified email available

  • JeanVerified

    Venture Capital, Private Equity Firm · Switzerland

    Health CareWellnessWomen FoundedLife Science

    Portfolio: Borean Pharma, Ikaria, Synosia Therapeutics, MerLion Pharma and 15 more

    Verified email available

  • Cheryl Zimberlin

    Venture Capital, Corporate Venture Capital, Investor · Netherlands

    SeedHealth CareConsumer GoodsInfrastructureLife Science

    Portfolio: FoRx Therapeutics, Micropsi Industries, Indi Molecular, Biolinq and 48 more

    Contact details available

  • Christian Patze

    Venture Capital, Corporate Venture Capital, Private Equity Firm · Germany

    SeedHealth CareDeepTechConsumer GoodsInfrastructure

    Portfolio: FoRx Therapeutics, Micropsi Industries, Indi Molecular, Biolinq and 48 more

    Contact details available

  • Diede Brunen

    Venture Capital, Private Equity Firm, Micro VC · Netherlands

    SeedPre-SeedHealth CareLife ScienceManufacturingBiotechnology

    Portfolio: Confo Therapeutics, Lanthio Pharma, Scenic Biotech, Cristal Therapeutics and 13 more

    Contact details available

  • Edward Van Wezel

    Venture Capital, Micro VC, Investor · Netherlands

    SeedPre-SeedHealth CareLife ScienceManufacturingBiotechnology

    Portfolio: Confo Therapeutics, Lanthio Pharma, Scenic Biotech, Cristal Therapeutics and 13 more

    Contact details available

  • Joost Holthuis

    Venture Capital, Micro VC, Investor · Netherlands

    SeedPre-SeedHealth CareLife ScienceManufacturingBiotechnology

    Portfolio: Confo Therapeutics, Lanthio Pharma, Scenic Biotech, Cristal Therapeutics and 13 more

    Contact details available

  • Max Klement

    Venture Capital, Micro VC, Investor · United Kingdom

    SeedPre-SeedHealth CareLife ScienceManufacturingBiotechnology

    Portfolio: Confo Therapeutics, Lanthio Pharma, Scenic Biotech, Cristal Therapeutics and 13 more

    Contact details available

  • Rob de Ree

    Venture Capital, Micro VC, Investor · Netherlands

    SeedPre-SeedHealth CareLife ScienceManufacturingBiotechnology

    Portfolio: Confo Therapeutics, Lanthio Pharma, Scenic Biotech, Cristal Therapeutics and 13 more

    Contact details available

  • Julian Schubert

    Venture Capital, Corporate Venture Capital · Germany

    Health CareConsumer GoodsInfrastructureChemical

    Portfolio: FoRx Therapeutics, Micropsi Industries, Indi Molecular, Biolinq and 48 more

    Contact details available

  • Wallace Wallace

    Venture Capital, Corporate Venture Capital · Netherlands

    Health CareConsumer GoodsInfrastructureLife Science

    Portfolio: FoRx Therapeutics, Micropsi Industries, Indi Molecular, Biolinq and 48 more

    Contact details available

Frequently asked questions

How many Synaffix BV investors are on Angel Roster?

Angel Roster lists 15 Synaffix BV investors. 6 of them (40%) include a verified email address.

What types of investors are they?

The most common investor types are Venture Capital Firms (15), Private Equity Firms (7) and Corporate Venture Capital Firms (7). An investor can have more than one type, for example an angel who is also a venture partner.

Which stages do Synaffix BV investors invest in?

Among those that list a stage, the most common are Seed (10) and Pre-Seed (6).

Where are Synaffix BV investors based?

Most are based in the Netherlands (8), Germany (3) and Switzerland (2).

Which companies have Synaffix BV investors backed?

The most-backed portfolio companies among them are Ambrx (9), Bird Rock Bio (9), Tipe (7), Akili Interactive Labs (7) and Galecto (7).

How do I contact Synaffix BV investors?

Create a free Angel Roster account to search and filter all 15, then unlock verified emails and LinkedIn profiles on a paid plan. Every plan starts with a 3-day free trial.